GLOBAL (NORTH AMERICA, EUROPE, ASIA-PACIFIC, SOUTH AMERICA, MIDDLE EAST AND AFRICA) MRSA DRUGS MARKET 2018, FORECAST TO 2023

Jan 2019 145

Delivery of the Report will take 2-3 working days once order is placed.

Synopsis

Staphylococcus aureus is a bacteria commonly found on nose or skin of healthy people. MRSA i.e., methicillin-resistant staphylococcus aureus, is thus a type of staphylococcus aureus that is resistant to beta-lactam antibiotic called methicillin. MRSA strains do not respond to methicillin treatment. Around 1% of the population carrying staphylococcus aureus on their nose or skin are infected by MRSA. The infection causes skin and tissue infection, and is transmitted by direct skin-to-skin contact.

Scope of the Report:
This report focuses on the MRSA Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
Methicillin-resistant Staphylococcus aureus (MRSA) is a skin infection that occurs mostly in hospitals and healthcare facilities. It is treated with commonly-used antibiotics and is highly contagious. This infection is difficult to treat because it is sometimes resistant to commonly-used antibiotics such as methicillin. As per this market research report, the aging people are highly susceptible to MRSA infections, especially in the hospital environment as their weak immune system makes them easily prone to diseases and infections.
The worldwide market for MRSA Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers
- Allergan
- Merck
- Pfizer
- Theravance Biopharma
- Absynth Biologics
- AmpliPhi Biosciences
- AstraZeneca
- Basilea Pharmaceutica
- Baxter
- Cellceutix
- Cempra
- CrystalGenomics
- Debiopharm
- Galapagos
- GSK
- KYORIN Pharmaceutical
- Lytix Biopharma
- Melinta Therapeutics
- Nabriva Therapeutics
- NovaDigm Therapeutics

Market Segment by Regions, regional analysis covers
- North America (United States, Canada and Mexico)
- Europe (Germany, France, UK, Russia and Italy)
- Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
- South America (Brazil, Argentina, Colombia etc.)
- Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers
- Tetracycline
- Folate antagonist
- Cephalosporin
- Lipopeptides
- Oxazolidinone
- Lipoglycopeptide

Market Segment by Applications, can be divided into
- Hospital
- Research
- Clinic
- Other

There are 15 Chapters to deeply display the global MRSA Drugs market.
Chapter 1, to describe MRSA Drugs Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of MRSA Drugs, with sales, revenue, and price of MRSA Drugs, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of MRSA Drugs, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, MRSA Drugs market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe MRSA Drugs sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Table of Contents

Related reports :

(Jun 19)

Dioscorea Polystachya is a species of flowering plant in the yam family, which grows throughout East Asia yet native to C Sco...

(Jun 19)

Chinese Yam is a species of flowering plant in the yam family, which grows throughout East Asia yet native to China. Scope of...

(Jun 19)

Cicada Shell is the shell of insect Cryptotympana pustulata Fabricius, the family of Cicadidae. Scope of the Report: T...

(Jun 19)

Cicada Slough is the shell of insect Cryptotympana pustulata Fabricius, the family of Cicadidae. Scope of the Report: ...

(Jun 19)

Periostracum Cicadae is the skin that has been removed from Cicada, which has medicinal value. Scope of the Report: Th...

(Jun 19)

Ganoderma lucidum, commonly known as the lingzi mushroom, is frequently used in traditional Chinese medicine. Its popularity extends to Japa...

GLOBAL (NORTH AMERICA, EUROPE, ASIA-PACIFIC, SOUTH AMERICA, MIDDLE EAST AND AFRICA) MRSA DRUGS MARKET 2018, FORECAST TO 2023


Share this report on:

Subscription Option


Using our subscription option, you get access to Market Research Reports and industry data of Medicine and Pharmacy market as per your needs. Get the best of Medicine and Pharmacy research reports by utilizing your research budgets in an optimum way. Contact for details

Contact for reports

*

Avail 15% Discount, Use JUNE15 Coupon Code

We use cookies to deliver the best possible experience on our website.
By continuing to use this site, or closing this box, you consent to our use of cookies. To learn more, visit our Privacy Policy